Given the co-mutation phenomenon of TP53 and KRAS, three mutation phenotypes (“Double-WT,” “Single-Hit,” and “Double-Hit”) were identified in ICC patients. Here, KRAS is linked to intrahepatic cholangiocarcinoma.